Reperfusion Injury  >>  Berinert (C1 esterase inhibitor (human) IV)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Berinert (C1 esterase inhibitor (human) IV) / CSL Behring
C1INHDGF, NCT02134314: C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

Completed
1/2
70
US
C1 Esterase Inhibitor, Berinert (C1INH), Placebo, Normal Saline (0.9%NaCl)
Cedars-Sinai Medical Center
End Stage Renal Disease, Kidney Failure, Delayed Graft Function, Ischemic Reperfusion Injury
03/17
03/17
NCT04696146: Berinert (C1INH) vs Placebo for DGF/IRI

Active, not recruiting
1/2
45
US
Berinert, C1 Esterase Inhibitor (C1INH), Placebo, Normal Saline
Cedars-Sinai Medical Center, OneLegacy Foundation
End Stage Renal Disease, Chronic Kidney Diseases
07/22
03/24

Download Options